Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Fabry disease | D000795 | Orphanet_324 | E75.21 | 7 | 13 | 15 | 9 | 25 | 65 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | 1 | — | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | — | — | — | 1 | 1 |
Renal dialysis | D006435 | EFO_0010690 | Z99.2 | — | — | — | — | 1 | 1 |
Abdominal pain | D015746 | HP_0002027 | R10.9 | — | — | — | — | 1 | 1 |
Colic | D003085 | HP_0011848 | R10.83 | — | — | — | — | 1 | 1 |
Flatulence | D005414 | — | R14.3 | — | — | — | — | 1 | 1 |
Hypertrophic cardiomyopathy | D002312 | EFO_0000538 | I42.1 | — | — | — | — | 1 | 1 |
Lysosomal storage diseases | D016464 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Agalsidase alfa |
INN | agalsidase alfa |
Description | Replagal (agalsidase alfa) is an enzyme pharmaceutical. Agalsidase alfa was first approved as Replagal on 2001-08-03. It has been approved in Europe to treat fabry disease. |
Classification | Enzyme |
Drug class | enzymes |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | 1R46, 1R47 |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108214 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 2HLC17MX9G (ChemIDplus, GSRS) |